BML 4.81 Decreased By ▼ -0.10 (-2.04%)
BOP 12.74 Decreased By ▼ -0.32 (-2.45%)
CNERGY 7.01 Decreased By ▼ -0.11 (-1.54%)
CPHL 83.34 Decreased By ▼ -1.31 (-1.55%)
DCL 13.24 Decreased By ▼ -0.48 (-3.5%)
DGKC 171.80 Decreased By ▼ -1.54 (-0.89%)
FCCL 46.05 Decreased By ▼ -0.55 (-1.18%)
FFL 15.57 Decreased By ▼ -0.13 (-0.83%)
GCIL 26.58 Decreased By ▼ -0.09 (-0.34%)
HUBC 148.14 Decreased By ▼ -2.25 (-1.5%)
KEL 5.31 Increased By ▲ 0.04 (0.76%)
KOSM 6.24 Decreased By ▼ -0.16 (-2.5%)
LOTCHEM 20.67 Decreased By ▼ -0.09 (-0.43%)
MLCF 84.02 Decreased By ▼ -1.42 (-1.66%)
NBP 124.95 Decreased By ▼ -3.90 (-3.03%)
PAEL 40.96 Decreased By ▼ -1.09 (-2.59%)
PIAHCLA 21.84 Decreased By ▼ -0.32 (-1.44%)
PIBTL 10.14 Increased By ▲ 0.05 (0.5%)
POWER 14.00 Increased By ▲ 0.06 (0.43%)
PPL 163.05 Decreased By ▼ -0.91 (-0.56%)
PREMA 41.44 Decreased By ▼ -0.54 (-1.29%)
PRL 31.98 Decreased By ▼ -0.84 (-2.56%)
PTC 22.80 Decreased By ▼ -0.76 (-3.23%)
SNGP 115.12 Decreased By ▼ -2.85 (-2.42%)
SSGC 44.06 Decreased By ▼ -1.19 (-2.63%)
TELE 7.75 Decreased By ▼ -0.25 (-3.13%)
TPLP 9.90 Decreased By ▼ -0.22 (-2.17%)
TREET 23.48 Decreased By ▼ -0.49 (-2.04%)
TRG 55.84 Decreased By ▼ -1.17 (-2.05%)
WTL 1.49 Decreased By ▼ -0.03 (-1.97%)
BR100 14,134 Decreased By -4.9 (-0.03%)
BR30 39,571 Decreased By -563.9 (-1.4%)
KSE100 138,597 Decreased By -68.1 (-0.05%)
KSE30 42,341 Decreased By -12.3 (-0.03%)
World

Germany's COVID-19 vaccination centres to hit capacity by end of March

  • Germany has so far been starved of shots as drugmakers faced production problems, but shortages are likely to ease as deliveries accelerate.
  • BioNTech's shot, made in partnership with US drug company Pfizer, was the first to win approval for use in the European Union.
Published February 10, 2021

BERLIN: Germany will run up against limits on its capacity to inoculate people against COVID-19 by the end of March, health ministry documents showed, as an expected increase in supply puts its network of vaccination centres to the test.

Germany has so far been starved of shots as drugmakers faced production problems, but shortages are likely to ease as deliveries accelerate, according to a revised vaccine strategy released by the health ministry on Wednesday.

The strategy update came as German biotech startup BioNTech launched a new facility in the German town of Marburg, expecting first vaccines made there to be distributed in early April.

BioNTech's shot, made in partnership with US drug company Pfizer, was the first to win approval for use in the European Union.

Germany is also getting vaccines from Moderna and AstraZeneca. The Pfizer and Moderna shots need to be kept frozen, while Astra's can be stored in a fridge, making it suitable for administration by family doctors.

Around 2.4 million people have been vaccinated in Germany, or 2.9% of the population, since it started vaccinations in December, health ministry data showed.

Initial shortages should give way in the second quarter to more abundant supply, when Germany expects to receive 77 million vaccine doses. Chancellor Angela Merkel has promised shots to all adults who want one by the end of the summer.

To reach this target, vaccinations will be offered at general practitioners' clinics, working in parallel with the existing network of more than 400 vaccination centres, the plan document read.

"It is becoming clear that the vaccination centres will have to continue to operate for a longer period of time, even after doctors' practices are involved," it read.

In the plan, Germany's Institute for Statutory Health Care (Zi) recommended increasing the daily capacity of vaccination centres to 300,000 from 200,000 to meet targets.

According to Zi calculations and based on drugmakers' delivery commitments, Germany will be able to inoculate around three million people a week from May and administer around one million shots a day by the end of June.

Comments

Comments are closed.